BiotechTubeBiotechTube
Home/Shattuck Labs/Taylor H. Schreiber, MD, PhD
TH

Taylor H. Schreiber, MD, PhD

Chief Executive Officer, and Co-founder

Shattuck Labs

Therapeutic Areas

Inflammatory Bowel DiseaseAutoimmune DiseasesInflammatory Diseases

Shattuck Labs Pipeline

DrugIndicationPhase
SL-325Inflammatory Bowel Disease (IBD)Phase 2
SL-425Inflammatory Bowel Disease (IBD)Phase 1
BispecificsAutoimmune DiseasesIND-Enabling

Leadership Team at Shattuck Labs

LP
Lini Pandite, MD, MBA
Chief Medical Officer
CD
Casi DeYoung, MBA
Chief Business Officer
AR
Andrew R. Neill, MBA
Chief Financial Officer
View full Shattuck Labs profile